Target ID | Target Type | Target Name | Target Organism | Activity Type | Activity Relation | Value | Unit | Reference |
---|---|---|---|---|---|---|---|---|
NPT1107 | Organism | Mycobacterium smegmatis str. MC2 155 | Mycobacterium smegmatis str. MC2 155 | MIC | > | 200 | ug/ml | 20073490 |
NPT1108 | Organism | Mycobacterium bovis BCG | Mycobacterium bovis BCG | MIC | > | 200 | ug/ml | 17261619 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
●  The left chart: Distribution of similarity level between NPC472790 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Natural Product ID |
---|---|---|
0.6562 | Remote Similarity | NPC313504 |
0.6236 | Remote Similarity | NPC60537 |
0.6176 | Remote Similarity | NPC210947 |
0.6149 | Remote Similarity | NPC327477 |
0.614 | Remote Similarity | NPC286696 |
0.6116 | Remote Similarity | NPC472789 |
0.6082 | Remote Similarity | NPC470139 |
0.6047 | Remote Similarity | NPC185903 |
0.6036 | Remote Similarity | NPC126634 |
0.6 | Remote Similarity | NPC470140 |
0.5965 | Remote Similarity | NPC237812 |
0.5965 | Remote Similarity | NPC18223 |
0.5952 | Remote Similarity | NPC25465 |
0.5952 | Remote Similarity | NPC235501 |
0.5819 | Remote Similarity | NPC174020 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.
●  The left chart: Distribution of similarity level between NPC472790 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Drug ID | Developmental Stage |
---|---|---|---|
0.6889 | Remote Similarity | NPD3108 | Clinical (unspecified phase) |
0.6353 | Remote Similarity | NPD1451 | Approved |
0.6298 | Remote Similarity | NPD5768 | Phase 2 |
0.6236 | Remote Similarity | NPD2180 | Approved |
0.6221 | Remote Similarity | NPD568 | Approved |
0.6221 | Remote Similarity | NPD567 | Approved |
0.6221 | Remote Similarity | NPD566 | Approved |
0.614 | Remote Similarity | NPD875 | Clinical (unspecified phase) |
0.612 | Remote Similarity | NPD3130 | Discontinued |
0.6095 | Remote Similarity | NPD576 | Discontinued |
0.6064 | Remote Similarity | NPD3105 | Discontinued |
0.6034 | Remote Similarity | NPD5342 | Clinical (unspecified phase) |
0.5989 | Remote Similarity | NPD2604 | Approved |
0.5989 | Remote Similarity | NPD3697 | Discontinued |
0.5965 | Remote Similarity | NPD9133 | Approved |
0.5912 | Remote Similarity | NPD1731 | Clinical (unspecified phase) |
0.5905 | Remote Similarity | NPD8261 | Discontinued |
0.5872 | Remote Similarity | NPD9628 | Approved |
0.5819 | Remote Similarity | NPD9627 | Approved |
0.5747 | Remote Similarity | NPD8075 | Discontinued |
0.5714 | Remote Similarity | NPD7842 | Phase 2 |
0.5706 | Remote Similarity | NPD9183 | Clinical (unspecified phase) |
0.5621 | Remote Similarity | NPD300 | Approved |
PubChem CID   | |
ChEMBL   | CHEMBL3585845 |
ZINC   |
Molecular Weight:   | 878.47 |
ALogP:   | -2.1296 |
MLogP:   | 3.44 |
XLogP:   | -0.311 |
# Rotatable Bonds:   | 46 |
Polar Surface Area:   | 251.82 |
# H-Bond Aceptor:   | 20 |
# H-Bond Donor:   | 3 |
# Rings:   | 3 |
# Heavy Atoms:   | 60 |